Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Carmen M Valenzuela-Silva"'
Autor:
Francisco Hernández-Bernal, Carmen M Valenzuela-Silva, Karem M Catasús-Álvarez, Odalys C Lazo-Diago, Reinier Hernández-Rodríguez, Cimara H Bermúdez-Badell, Pedro A López-Saura, Ana T Fariñas-Reinoso
Publikováno v:
Revista Cubana de Higiene y Epidemiología, Vol 52, Iss 1, Pp 29-43
Introducción: la enfermedad hemorroidal constituye un problema de salud mundial y Cuba; sin embargo, la literatura no recoge información epidemiológica sobre la población cubana. Por lo que este trabajo caracteriza la enfermedad hemorroidal aguda
Externí odkaz:
https://doaj.org/article/730d46feb8e84ec686a43e9e636e817a
Autor:
Roberto Rodriguez‐Labrada, Ricardo Ortega‐Sanchez, Patricia Hernández Casaña, Orestes Santos Morales, Maria del Carmen Padrón‐Estupiñan, Maricela Batista‐Nuñez, Daise Jiménez Rodríguez, Nalia Canales‐Ochoa, Arnoy Peña Acosta, Jacqueline Medrano Montero, Pedro Enrique Labrada Aguilera, Annelie Estupiñán Rodriguez, Yaimee Vazquez‐Mojena, Dennis Almaguer Gotay, Judey Aymed‐García, Idrian García‐García, Reydenis Torres Vega, Carmen Viada González, Carmen M. Valenzuela Silva, Yanelis Silva Ricardo, Jorge Columbié Ximelis, Kenia Tribin Rivero, Roselin Valle Cabrera, Julio Cesar García‐Rodriguez, Tania Crombet Ramos, Daniel Amaro‐González, Teresita Rodriguez‐Obaya, Luis Velázquez‐Pérez
Publikováno v:
Movement Disorders. 37:1516-1525
Several pieces of evidence have shown the neurotrophic effect of erythropoietin (EPO) and its introduction in the therapeutic practice of neurological diseases. However, its usefulness in the treatment of spinocerebellar ataxia type 2 (SCA2) has not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7b22b1c3c3fd79d6f1e9a399834eae
https://doi.org/10.1002/mds.29045
https://doi.org/10.1002/mds.29045
Autor:
Franciscary Pi-Estopinan, Jorman Rubino-Moreno, Mayte Amoroto-Roig, Maria Teresa Perez-Guevara, Yury Valdés-Balbín, Laura M. Rodríguez-Noda, Marisel Martinez-Perez, Meiby de la Caridad Rodriguez-Gonzalez, Carmen M Valenzuela-Silva, Dagmar García-Rivera, Rolando Ochoa-Azze, Maura Tamayo-Rodriguez, Raul Gonzalez-Mugica, Vicente Verez-Bencomo, Yanet Chappi-Estevez, Yanet Climent-Ruiz, Belinda Sanchez-Ramirez, Beatriz Paredes-Moreno, Anamary Suarez-Batista, Gretchen Bergado-Baez, Tays Hernandez-Garcia, Alina Díaz-Machado, Alis Martín-Trujillo, Sonia Pérez-Rodríguez, Rocmira Perez-Nicado, Guang-Wu Chen, Marta Dubed-Echevarría, Carlos A. González-Delgado
Publikováno v:
Vaccine. 40:2068-2075
BackgroundThe Receptor Binding Domain (RBD) of the SARS-CoV-2 spike protein is the target for many COVID-19 vaccines. Here we report results for phase 1 clinical trial of two COVID-19 vaccine candidates based on recombinant dimeric RBD (d-RBD).Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b445b9be96c36bcec3631c8577e62bff
https://doi.org/10.1016/j.vaccine.2022.02.029
https://doi.org/10.1016/j.vaccine.2022.02.029
Autor:
Jorge F. Pérez-Oliva Díaz, Martha Casanova González, Orosmán Cuesta Panaco, Osniel Bencomo Rodríguez, Beatriz López Tórres, Claudio González, Liván Cruz Benítez, Idrian García García, Carmen M. Valenzuela Silva
Publikováno v:
Revista Habanera de Ciencias Médicas, Vol 12, Iss 3 (2013)
RESUMEN INTRODUCCION: La anemia renal es frecuente en la enfermedad renal crónica avanzada y el tratamiento con eritropoyetina recombinante humana la mejora pero aún está a debate cual objetivo de hemoglobina alcanzar y cuál es su repercusión so
Externí odkaz:
https://doaj.org/article/08bfeec90fea49839035b011f0b77a2d
Autor:
Mauro M. Teixeira, Julio R. Fernández-Massó, Alessandra Bergami, Nadia Polentarutti, Carmen M Valenzuela-Silva, Tania Veliz-Rodriguez, Alexey Llópiz-Arzuaga, Javier Marín-Prida, Nielsen Lagumersindez-Denis, Tania Herrera-Rolo, Marcelo Nazabal-Galvez, Roberto Furlan, Luca Muzio, Eduardo Pentón-Arias, Ivette Raíces-Cruz, Giselle Pentón-Rol
Publikováno v:
Journal of Neuroimmune Pharmacology. 11:153-167
Multiple Sclerosis (MS) therapies approved so far are unable to effectively reverse the chronic phase of the disease or improve the remyelination process. Here our aim is to evaluate the effects of C-Phycocyanin (C-Pc), a biliprotein from Spirulina p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a161f404a532be68b695d803b6d4524b
https://doi.org/10.1007/s11481-015-9642-9
https://doi.org/10.1007/s11481-015-9642-9
Autor:
Nancy Pavón-Fuentes, Majel Cervantes-Llanos, Javier Marín-Prida, Julio R. Fernández-Massó, Eduardo Pentón-Arias, Beatriz Piniella-Matamoros, Hanlet Camacho-Rodríguez, Nielsen Lagumersindez-Denis, Viviana Falcón-Cama, Carmen M Valenzuela-Silva, Giselle Pentón-Rol, Ivette Raíces-Cruz, Mauro M. Teixeira
Publikováno v:
Life sciences. 194
The only three oral treatments currently available for multiple sclerosis (MS) target the relapsing forms of the disease and concerns regarding efficacy, safety and tolerability limit their use. Identifying novel oral disease-modifying therapies for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e7cb2f556ede62621a002750f9c44d1
https://pubmed.ncbi.nlm.nih.gov/29287781
https://pubmed.ncbi.nlm.nih.gov/29287781
Autor:
Rosario Campos-Mojena, Alieski Cruz-Ramírez, Ángela D. Tuero-Iglesias, Iraldo Bello-Rivero, Alina Díaz-Machado, Sonia Pérez-Rodríguez, Pedro Lopez-Saura, Alis Martín-Trujillo, Ignacio Hernández-González, Carmen M Valenzuela-Silva, Hector Santana-Milian, Carlos A. González-Delgado, Idrian García-García, Yanelda García-Vega
Publikováno v:
BMC Pharmacology & Toxicology
More potent antitumor activity is desired in Interferon (IFN)-treated cancer patients. This could be achieved by combining IFN alpha and IFN gamma. The aim of this work was to characterize the pharmacokinetics and pharmacodynamics of a novel formulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::268afa09b3a2a1a743d3a901e6e22b39
https://doi.org/10.1186/s40360-016-0103-8
https://doi.org/10.1186/s40360-016-0103-8
Autor:
Bello-Alvarez C, Carmen M Valenzuela-Silva, Vázquez-Blomquist D, Garcia-Vega Y, Pedro Lopez-Saura, I. Bello-Rivero
Publikováno v:
Journal of Cancer Research & Therapy, Vol 1, Iss 10, Pp 235-243 (2013)
Purpose: This work is aimed to show briefly, the clinical development of a new pharmaceutical formulation of interferons for the treatment of basal cell carcinoma. Methods: A rationale design of the combination of IFN-α2b and -γ based in their anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0182509b0589bc0716ca5a5f05211746
https://doi.org/10.14312/2052-4994.2013-36
https://doi.org/10.14312/2052-4994.2013-36
Autor:
Carmen M Valenzuela-Silva, Elizeth García-Iglesias, José I Fernández-Montequín, Amaurys del Río-Martín, Isis Belkis Yera Alos, Ángela D. Tuero-Iglesias, Odalys González-Díaz, Pedro Lopez-Saura
Publikováno v:
Diabetes Care
OBJECTIVE To determine if partial wound closure surrogate markers proposed for neuropathic, small diabetic foot ulcers (DFUs) can be extended to advanced lesions and if the development of granulation tissue can be used to predict complete healing. RE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::601c6391d0c5aa14e57248849eb1cda0
https://doi.org/10.2337/dc12-1323
https://doi.org/10.2337/dc12-1323
Autor:
Odalys González Díaz, Heriberto Artaza-Sanz, José I Fernández-Montequín, Carlos M Hernández-Cañete, Pedro Lopez-Saura, William Savigne, Carmen M Valenzuela-Silva, Fidel Rivero-Fernández, Natasha Sancho-Soutelo, Pablo Sánchez-Penton, Lourdes Morejón-Vega, Cecilio González-Benavides, Alberto Vázquez-Proenza, Arístides García-Herrera, Jorge Berlanga-Acosta
Publikováno v:
Int Wound J
Fernández‐Montequín JI, Valenzuela‐Silva CM, González Díaz O, Savigne W, Sancho‐Soutelo N, Rivero‐Fernández F, Sánchez‐Penton P, Morejón‐Vega L, Artaza‐Sanz H, García‐Herrera A, González‐Benavides C, Hernández‐Cañete CM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c8e67556f4fc1c55af9e32219e57323
https://doi.org/10.1111/j.1742-481x.2009.00641.x
https://doi.org/10.1111/j.1742-481x.2009.00641.x